Lifeboat Foundation

A documentary film just had its premiere at the Hot Docs festival in Toronto. How To Build A Time Machine, the work of filmmaker Jay Cheel, is a strange and incoherent little document of two middle-aged men with loosely related obsessions: One of them wants to build a perfect recreation of a movie prop – the machine from the 1960 movie The Time Machine, based on the H.G. Wells novel – and the other is a theoretical physicist who thinks he may have effected a kind of time travel in a lab, on a microscopic scale, using lasers that push particles around. The weak connection between the two men is that they both regret a death in their past – a best friend, a father – and are preoccupied with what they might have done to prevent the death; they both wonder if time travel to the past might have been a remedy for death itself. (Compared to the protagonist of Zero K who seeks immortality as a way of avoiding the loss of a loved one.) The 80s synthpop song Forever Young by Alphaville booms symbolically at one point.

Why this sudden ascendancy of yearning for immortality now? Is it simply because immortality of a medical sort might be imminent, a result of technological advances, such as nanobots, that will fight disease in our bloodstream? Or is it because, as Ray Kurzweil implies, digital technology is now so advanced that we have already left our bodies behind? We already live outside them, and our digital selves will outlive them. (“I mean,” says Kurzweil, “this little Android phone I’m carrying on my belt is not yet inside my physical body, but that’s an arbitrary distinction.”)

The frequently quoted axiom of Arthur C. Clarke – “Any sufficiently advanced technology is indistinguishable from magic” – is pertinent to this current fascination with life without end. We are now perceiving technology as not just magic but as god-like, as life-giving, as representing an entirely new plane of being.

Continue reading “Russell Smith: What’s behind our sudden fascination with immortality?” »

Chinese technology giant Huawei is preparing for a world where people live forever, dead relatives linger on in computers and robots try to kill humans.

Huawei is best known as one of the world’s largest producers of broadband network equipment and smartphones. But Kevin Ho, president of its handset product line, told the CES Asia conference in Shanghai on Wednesday the company used science fiction movies like “The Matrix” to envision future trends and new business ideas.

“Hunger, poverty, disease or even death may not be a problem by 2035, or 25 years from now,” he said. “In the future you may be able to purchase computing capacity to serve as a surrogate, to pass the baton from the physical world to the digital world.”

Continue reading “Huawei Prepares for Robot Overlords and Communication with the Dead” »

EPFL researchers have restored the ability of mice organs to regenerate and extend life by simply administering nicotinamide riboside (NR) to them.

NR has been shown in previous studies to be effective in boosting metabolism and treating a number of degenerative diseases. Now, an article by PhD student Hongbo Zhang published in Science also describes the restorative effects of NR on the functioning of stem cells for regenerating organs.

Continue reading “This vitamin stops the aging process in organs, say Swiss researchers” »

Japanese scientists have reported the first successful skin-to-eye stem cell transplant in humans, where stem cells derived from a patient’s skin were transplanted into her eye to partially restore lost vision.

The patient, a 70-year-old woman diagnosed with age-related macular degeneration (AMD) – the leading cause of vision impairment in older people – received the experimental treatment back in 2014 as part of a pilot study. Now, closing in on two years after the transplant took place, the scientists are sharing the results.

The researchers took a small piece of skin from her arm (4 mm in diameter) and modified its cells, effectively reprogramming them into induced pluripotent stem cells (iPSC).

Continue reading “Japanese scientists have used skin cells to restore a patient’s vision for the first time” »

New story and video on transhumanism from Vocativ:

His name is Zoltan Istvan, and he’s running on the Transhumanist ticket.

Continue reading “The transhumanist presidential candidate wants you to live forever” »

They are worth 6 billion dollars.

They are calling him the Elon Musk of biology. But will we see an end to aging soon?

Continue reading “The End of Aging? Soon It Might Be a Prescription Away” »

Interesting article by CNET, the leading tech site in traffic, on how a strong science, longevity, and technology platform could end up in Washington in 2016:

CNET exclusive: The only pro-immortality candidate could eventually team up with one of the big names in the race.

The new entity will focus on a haemophilia pipeline utilising the XTEN half-life extension technology, bispecific antibodies and gene therapies.

Biogen announced yesterday it is planning to spin-out its haemophilia business into an independent, public firm based in Boston, Massachusetts by early next year.

Management said during a conference call this was the right time for a spin-out as Biogen’s haemophilia business has matured.

Continue reading “Biogen haemophilia spin-out to develop gene therapies and long-acting factors” »

When tweaking its architecture, the adult brain works like a sculptor—starting with more than it needs so it can carve away the excess to achieve the perfect design. That’s the conclusion of a new study that tracked developing cells in an adult mouse brain in real time.

New brain cells began with a period of overgrowth, sending out a plethora of neuronal branches, before the brain pruned back the connections. The observation, described May 2, 2016 in Nature Neuroscience, suggests that new cells in the adult brain have more in common with those in the embryonic brain than scientists previously thought and could have implications for understanding diseases including autism, intellectual disabilities and schizophrenia.

“We were surprised by the extent of the pruning we saw,” says senior author Rusty Gage, a professor in Salk’s Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease.